News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016
SoCal's Puma Biotech (PBYI) Delays NDA for Neratinib to Treat Breast Cancer Until Mid-2016     3/29/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Breast Cancer Pipeline Has More than 1,000 Drugs in Development     3/9/2016
Immunomedics (IMMU)'s Breast Cancer Drug Wins Breakthrough Tag from the FDA     2/5/2016
NanoString (NSTG) Touts Collaborative Work in Immuno-Oncology at J.P. Morgan Conference     1/11/2016
Investors Await Four Key FDA Decisions in the First Quarter of 2016     1/5/2016

News from Around the Web
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016
Hops Extract Could Help Reduce Breast Cancer Risk, University of Illinois Study     7/12/2016
Why Do More Black Women Die of Breast Cancer? NIH Study     7/8/2016
NASA Technology Reveals Bacteria's Role In Breast Cancer     6/28/2016
In Mice, Daughters Of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk, Georgetown University Medical Center Study     6/27/2016
4 Things You Can Do To Decrease The Chance Your Breast Cancer Risk, Study Published In JAMA     6/3/2016
Breast Cancer Drug Found To Reduce Seizures, Northwestern University Study     5/24/2016

Press Releases
Acelity Introduces ALLODERM SELECT DUO Regenerative Tissue Matrix     10/19/2016
New CDC Study Shows Changes In Breast Cancer Death Rates By Age Group     10/13/2016
PharmaMar Announces Positive Results From Its Phase II Study With Lurbinectedin In BRCA 1/2 - Associated Metastatic Breast Cancer At The ESMO 2016 Congress     10/10/2016
Daiichi Sankyo Presents Late-Breaking Phase 1 Data For Novel Investigational HER2-Targeting Antibody Drug Conjugate DS-8201a In T-DM1 Pre-Treated Breast Cancer At The ESMO 2016 Congress     10/10/2016
Novartis AG (NVS) Challenges Pfizer (PFE) Full on With New Breast Cancer Data     10/10/2016
ZIOPHARM Oncology (ZIOP) Falls Some More After Experimental Gene Therapy is Tied to 'Higher Than Expected' Toxicity     10/10/2016
Cascadian Therapeutics (ONTY) Announces Presentation Of Tucatinib In Combination Therapy In Patients With Cutaneous HER2+ Metastatic Breast Cancer     10/10/2016
Peregrine (PPHM) Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance The Anti-Tumor Activity Of Multiple Checkpoint Targeting Agents In Model Of Triple Negative Breast Cancer (TNBC)     9/27/2016
Daiichi Sankyo To Present At ESMO 2016 Late-Breaking Clinical Data For Novel HER2-Targeting Antibody Drug Conjugate In T-DM1 Pre-Treated Breast Cancer     9/27/2016
First Patient Enrolled In Toca 6, Tocagen's Trial For Metastatic Cancers Evaluating Intravenously Delivered Toca 511 Virus     9/22/2016
Puma Biotech (PBYI) Announces FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer     9/20/2016
Abilita Bio Awarded NCI Phase-I SBIR Grant To Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer     9/20/2016
Two New Studies Demonstrate Advantages Of Andrew Technologies, Inc.’ Hydrasolve As The Company Heads To ASPS 2016     9/19/2016
Pfizer (PFE) Receives Positive CHMP Opinion For IBRANCE (Palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe     9/16/2016
Navidea (NAVB)’s Lymphoseek Receives Positive Opinion In Europe For A New Reduced Mass Vial     9/16/2016